Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial. [electronic resource]
Producer: 20070702Description: 39-45 p. digitalISSN:- 1097-6744
- Abciximab
- Antibodies, Monoclonal -- administration & dosage
- Clinical Trials, Phase III as Topic
- Drug Administration Schedule
- Follow-Up Studies
- Humans
- Immunoglobulin Fab Fragments -- administration & dosage
- Infusions, Intravenous
- Metals
- Myocardial Infarction -- therapy
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Randomized Controlled Trials as Topic
- Research Design
- Sirolimus -- administration & dosage
- Stents
- Tirofiban
- Tyrosine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.